Effect of Exercise as Non-surgical Treatments on Time to Total Hip Replacement Surgery (HipSPORT)

May 4, 2018 updated by: Carsten Jensen, University of Southern Denmark

The Effect of Education and Supervised Exercise vs. Education Alone on Time to Total Hip Replacement in Patients With Hip Osteoarthritis Considered Eligible for Surgery

The aim of this trial is to test the hypothesis that patients with severe hip osteoarthritis postpone time to hip replacement surgery following participation in a patient education and supervised exercise program when compared to patients receiving patient education alone.

Study Overview

Status

Completed

Conditions

Detailed Description

Hip replacements are performed at an increasing rate, also in younger and less disabled patients. Recent studies indicate non-surgical interventions being effective in reducing pain and disability also at later stages of disease when hip replacement is considered. Possible, non-surgical treatments can be used to postpone hip replacement. The effect of education and supervised exercise on time to hip replacement is largely unknown

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Odense, Denmark, 5200
        • Dept. of Orthopedic Surgery and Traumatology, Odense University Hospital, Denmark
      • Vejle, Denmark, 7100
        • Sector for Hip and Knee Replacement, Dept. of Orthopaedics, Vejle Hospital, Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 40 years and older
  • Indication for total hip arthroplasty
  • Residency within local municipal or willing to commute

Exclusion Criteria:

  • Inflammatory joint disease
  • Earlier ipsilateral proximal femur fracture
  • Hip pain < 3 months
  • Neuropathy or neuromuscular disease
  • Malignant disease
  • Diseases where a moderate level of physical exercise is contraindicated
  • Unable to speak or read Danish
  • Unable to participate for other reasons
  • Refuse to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supervised exercise and patient education
The entire duration of the intervention is 12 weeks, and consists of 24 sessions each lasting 60-70 minutes. Patients will receive two types of exercises, delivered on separate days. One type of exercise is individualized, goal-based neuromuscular training (NEMEX) in groups with progression guided by the patient's neuromuscular function (12 sessions). The other type of exercise is individualized, intensive resistance training (RT) in groups with each exercise progression guided by load (12 sessions).
Patients in the exercise groups will receive two types of exercise, delivered on separate days. One type of exercise is individualized, goal-based neuromuscular training (NEMEX-TJR) in groups with progression guided by the patient's neuromuscular function. The other type of exercise is individualized, intensive resistance training (RT) in groups with each exercise progression guided by load. Each of the two types of exercise will be offered weekly during the 12 week intervention period in sessions lasting 60-70 minutes. Thus, the entire exercise intervention consists of 24 sessions
Other Names:
  • NEMEX-TJR and RT
The patient education program is designed to educate the patients about hip osteoarthritis during 3 sessions of 90 min. duration
Other Names:
  • BOA
Other: Patient Education
The patient education program is designed to educate the patients about hip OA during 3 sessions of 90 min. duration
The patient education program is designed to educate the patients about hip osteoarthritis during 3 sessions of 90 min. duration
Other Names:
  • BOA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative Survival analysis (Kaplan-Maier survival curve)
Time Frame: one year
Cumulative Survival analysis as time in days without surgery since inclusion
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Hip disability and Osteoarthritis Outcome Score (HOOS 2.0)
Time Frame: Baseline, 3 and 12 months
HOOS is patient-reported outcome measure with 5 subscales for pain, other symptoms, function in daily living, function in sport and recreation and hip related Quality of Life. A 5-point Likert-scale is used and converted into a 100-point scale with zero indicating the worst possible health (http://www.koos.nu).
Baseline, 3 and 12 months
University of California Los Angeles activity score (UCLA)
Time Frame: Baseline, 3 and 12 months
Physical activity levels in populations. UCLA is a 10-point likert scale recommended and used extensively in similar populations
Baseline, 3 and 12 months
Global perceived effect (GPE) score
Time Frame: 3 and 12 months
Patients will be asked to rate possible change in their pain, symptoms, ADL, sports and recreation, quality of life, level of physical activity since the initial administration (baseline) on a 7-point Likert-scale.
3 and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported exercise pain (VAS-scale)
Time Frame: 3 months
Pain intensity using the VAS-scale. Participants will be followed for the duration of the exercise intervention (3 months) and be asked to rate pain intensity before and after each exercise session (total 24 sessions)
3 months
Exercise adherence
Time Frame: 3 months
'The extent to which a person's behavior corresponds with agreed recommendations from a health care provider' using no. of weeks, and no. of completed sessions
3 months
Cost-effectiveness analysis
Time Frame: 12 months
Cost-effectiveness analysis will be estimated as the ratio between cost of the intervention and the effect it produces. The total cost will be estimated from register-based costing of primary care, secondary care and patient's out-of-pocket costs (transportation expenses and time spent on transportation and receiving health care). Patient-reported values are weighted using Danish tariffs
12 months
General health status EuroQol (EQ-5D-5L)
Time Frame: Baseline, 3 and 12 months
The EQ-5D is a generic instrument for describing and valuing health. It is based on a descriptive system that defines health in terms of 5 dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression (http://www.euroqol.org)
Baseline, 3 and 12 months
Mechanical Muscle Function
Time Frame: Baseline, 3 and 12 months
Isometric muscle strength (iMVC) will be collected for knee extensors, hip extensors, -flexors and hip abductors.
Baseline, 3 and 12 months
Physical performance battery
Time Frame: Baseline, 3 and 12 months
Physical performance-based measures will include; 30 s chair stand (number completed), 20 meter fast-paced walk (time in (s)), 30 s single-leg knee bending (number completed), and timed up and go (time in sec.)
Baseline, 3 and 12 months
Poor compliance
Time Frame: 3 months
Reasons for poor compliance will be recorded.
3 months
Joint specific adverse events
Time Frame: 3 months
Joint specific adverse events will be determined as: 1) not attending a training session and/or ceasing training because of increased pain/problems in the index joint related to the training; and 2) self-reported exercise pain > 5 on the VAS-scale after training. The reasons for not attending a session due to pain/problems related to training or to other reasons will be recorded.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carsten Jensen, PhD, Orthopedic Research Unit, Dept. of Orthopedic Surgery and Traumatology, Odense University Hospital, Denmark. Institute of Clinical Research, University of Southern Denmark, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

August 1, 2017

Study Registration Dates

First Submitted

September 21, 2012

First Submitted That Met QC Criteria

September 26, 2012

First Posted (Estimate)

October 2, 2012

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 4, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on Supervised exercise

Subscribe